Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results: a rebuttal. Issue 6 (3rd July 2013) - Poller, L.; Jespersen, J.; Ibrahim, S.; Pattison, A.; ,